首页> 外文期刊>Gastrointestinal Endoscopy >Self-expandable metal stents for relieving malignant colorectal obstruction: short-term safety and efficacy within 30 days of stent procedure in 447 patients.
【24h】

Self-expandable metal stents for relieving malignant colorectal obstruction: short-term safety and efficacy within 30 days of stent procedure in 447 patients.

机译:自膨胀金属支架缓解恶性大肠梗阻:447例患者在支架手术后30天内的短期安全性和有效性。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: The self-expandable metal stent (SEMS) can alleviate malignant colonic obstruction and avoid emergency decompressive surgery. OBJECTIVE: To document performance, safety, and effectiveness of colorectal stents used per local standards of practice in patients with malignant large-bowel obstruction to avoid palliative stoma surgery in incurable patients (PAL) and facilitate bowel decompression as a bridge to surgery for curable patients (BTS). DESIGN: Prospective clinical cohort study. SETTING: Two global registries with 39 academic and community centers. PATIENTS: This study involved 447 patients with malignant colonic obstruction who received stents (255 PAL, 182 BTS, 10 no indication specified). INTERVENTION: Colorectal through-the-scope SEMS placement. MAIN OUTCOME MEASUREMENTS: The primary endpoint was clinical success at 30 days, defined as the patient's ability to maintain bowel function without adverse events related to the procedure or stent. Secondary endpoints were procedural success, defined as successful stent placement in the correct position, symptoms of persistent or recurrent colonic obstruction, and complications. RESULTS: The procedural success rate was 94.8% (439/463), and the clinical success rates were 90.5% (313/346) as assessed on a per protocol basis and 71.6% (313/437) as assessed on an intent-to-treat basis. Complications included 15 (3.9%) perforations, 3 resulting in death, 7 (1.8%) migrations, 7 (1.8%) cases of pain, and 2 (0.5%) cases of bleeding. LIMITATIONS: No control group. No primary endpoint analysis data for 25% of patients. CONCLUSION: This largest multicenter, prospective study of colonic SEMS placement demonstrates that colonic SEMSs are safe and highly effective for the short-term treatment of malignant colorectal obstruction, allowing most curable patients to have 1-step resection without stoma and providing most incurable patients minimally invasive palliation instead of surgery. The risk of complications, including perforation, was low.
机译:背景:自膨胀金属支架(SEMS)可缓解恶性结肠梗阻并避免紧急减压手术。目的:记录在恶性大肠梗阻患者中按照当地实践标准使用的结直肠支架的性能,安全性和有效性,以避免可治愈患者的姑息性造口手术(PAL)并促进肠减压,从而成为可治愈患者手术的桥梁(防弹少年团)。设计:前瞻性临床队列研究。地点:两个全球注册表,拥有39个学术和社区中心。患者:本研究涉及447例接受支架治疗的恶性结肠梗阻患者(255 PAL,182 BTS,10个未指定适应症)。干预:结直肠癌通过SEMS放置。主要观察指标:主要终点指标是30天时的临床成功率,其定义为患者保持肠功能的能力而没有与手术或支架相关的不良事件。次要终点是手术成功,定义为成功将支架正确放置在正确的位置,持续或复发性结肠梗阻的症状以及并发症。结果:按方案评估,手术成功率为94.8%(439/463),临床成功率为90.5%(313/346),按意向评估为71.6%(313/437)。处理基础。并发症包括15个(3.9%)穿孔,3例导致死亡,7例(1.8%)迁移,7例(1.8%)疼痛和2例(0.5%)出血。限制:无对照组。没有针对25%患者的主要终点分析数据。结论:这项对结肠SEMS放置的最大的多中心前瞻性研究表明,结肠SEMS对恶性大肠梗阻的短期治疗是安全且高效的,允许大多数可治愈的患者进行一步切除而没有造口,并且为大多数无法治愈的患者提供最少的服务侵入性缓解而不是手术。包括穿孔在内的并发症风险很低。

著录项

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号